Clinical Trial Update: Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating rhMBP-2/CPM for osteoarthritis in open wedge osteotomies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• rhMBP-2/CPM

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Osteoarthritis | Phase 1 | Status: COMPLETED